KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30

KAZIA THERAPEUTICS LTD

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 7, 2025

$7.85+0.60 (+8.28%)

Close on Oct 19, 2026

Community

Notes and questions about Kazia Therapeutics from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Kazia Therapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Apr 17, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is KZIA.

Revenue growth-98.2% · median -72.8%

Net margin-49290.5% · median -467453.1%

Advertisement
300 × 250